Patents by Inventor Michael Prentice Taylor

Michael Prentice Taylor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of inhibiting AB-type bacterial toxins and treatment for associated diseases
    Patent number: 9205068
    Abstract: Disclosed herein are compounds useful in inhibiting the action of AB-type bacterial toxins such as cholera, traveler's diarrhea, enterohemorrhagic diarrhea caused by E. coli O157:H7 and pertussis or whooping cough. Also included in the invention is the use of these compounds in treatment of diseases associated with those toxins.
    Type: Grant
    Filed: January 3, 2013
    Date of Patent: December 8, 2015
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Kenneth Robert Teter, Michael Prentice Taylor
  • Method of Inhibiting AB-Type Bacterial Toxins and Treatment for Associated Diseases
    Publication number: 20130244992
    Abstract: Disclosed herein are compounds useful in inhibiting the action of AB-type bacterial toxins such as cholera, traveler's diarrhea, enterohemorrhagic diarrhea caused by E. coli O157:H7 and pertussis or whooping cough. Also included in the invention is the use of these compounds in treatment of diseases associated with those toxins.
    Type: Application
    Filed: January 3, 2013
    Publication date: September 19, 2013
    Applicant: Univerity of Central Florida Research Foundation, Inc.
    Inventors: Kenneth Robert Teter, Michael Prentice Taylor
  • Method of inhibiting AB-type bacterial toxins and treatment for associated diseases
    Patent number: 8436048
    Abstract: Disclosed herein are compounds useful in inhibiting the action of AB-type bacterial toxins such as cholera, traveler's diarrhea, enterohemorrhagic diarrhea caused by E. coli O157:H7 and pertussis or whooping cough. Also included in the invention is the use of these compounds in treatment of diseases associated with those toxins.
    Type: Grant
    Filed: August 7, 2009
    Date of Patent: May 7, 2013
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Kenneth Robert Teter, Michael Prentice Taylor